ClinicalTrials.Veeva

Menu

Prevention of Intrauterine Adhesions After Hysteroscopic Metroplasty With Autocross-linked Hyaluronic Acid Gel

U

University of Cagliari

Status

Unknown

Conditions

Intrauterine Adhesions
Septate Uterus

Treatments

Procedure: Hysteroscopic metroplasty
Device: Autocross-linked acid hyaluronic gel
Procedure: Office second look hysteroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT02404454
MulticentricMetroplasty

Details and patient eligibility

About

The septate uterus is the most common structural uterine anomaly. It results from failure of the partition between the two fused Müllerian ducts to resorb;it is associated with the highest incidence of reproductive failure and with first- and second-trimester pregnancy loss and infertility.

Hysteroscopic division of the uterine septum is performed using microscissors, electrosurgery, or laser. Several studies shown significant improvement in pregnancy outcome after hysteroscopic metroplasty.

Purpose of this study is to verify the effectiveness of 5 ml, instead of 10 ml, of autocross-linked hyaluronic acid gel in the prevention of the formation of intrauterine adhesions, through second look office hysteroscopy after three months.

Enrollment

50 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • uterine septum
  • history of ≥1 miscarriage or infertility;
  • desire to have children in the future

Exclusion criteria

  • pregnancy;
  • menopause;
  • precancerous state or malignancy of the reproductive organs;
  • benign lesions in the myometrium of the uterine fundus (myomas or adenomyosis)
  • lesions distorting the uterine cavity (submucosal myomas or intrauterine adhesions) on ultrasonography;
  • withdrawal of patient consent;
  • rare complex uterine congenital anomalies without an ASRM classification such as uterine septum with double cervix ;
  • presence of external intercornual cleft;
  • incomplete (internal fundal indentation 10 mm) or non-standardized septum resection (internal fundal indentation ,10 mm and uterine myometrial thickness .10 mm at the fundus), confirmed intraoperatively
  • excessive fundal incision (uterine myometrial thickness ,6 mm at the fundus confirmed intraoperatively)

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

hysteroscopic metroplasty
Experimental group
Description:
women undergoing hysteroscopic metroplasty for uterine septum resection
Treatment:
Procedure: Office second look hysteroscopy
Device: Autocross-linked acid hyaluronic gel
Procedure: Hysteroscopic metroplasty

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems